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Themammalian pancreas is constructed during
embryogenesis by multipotent progenitors, the
identity and function of which remain poorly
understood. We performed genome-wide tran-
scription factor expression analysis of the de-
veloping pancreas to identify gene expression
domains that may represent distinct progenitor
cell populations. Five discrete domains were
discovered. Genetic lineage-tracing experi-
ments demonstrate that one specific domain,
located at the tip of the branching pancreatic
tree, contains multipotent progenitors that
produce exocrine, endocrine, and duct cells
in vivo. These multipotent progenitors are
Pdx1+Ptf1a+cMycHighCpa1+ and negative for
differentiated lineage markers. The outgrowth
of multipotent tip cells leaves behind differenti-
ated progeny that form the trunk of the
branches. These findings define a multipotent
compartment within the developing pancreas
and suggest a model of how branching is coor-
dinated with cell type specification. In addition,
this comprehensive analysis of >1,100 tran-
scription factors identified genes that are likely
to control critical decisions in pancreas devel-
opment and disease.
INTRODUCTION
Mammalian organs contain millions of cells and many
different cell types, all of which arise from a small number
of embryonic cells, the multipotent progenitors. Despite
their importance, rather little is known about when multi-
potent progenitors arise or how they guide organ con-
struction. The present study is concernedwith multipotent
progenitors in the pancreas. We identify genetic markers
for these cells and show where they are positioned and
how their progeny give rise to the branching organ and
its exocrine and endocrine components.DevelThe pancreas first appears as two separate buds
around Embryonic Day (E) 9.5 through evagination of the
early gut endoderm. The buds grow and initiate branching
at around E11.5 by sending finger-like epithelial protru-
sions into the surrounding mesenchyme. Successive
rounds of branching and further growth result in a three-
dimensional organ with a tree-like epithelial network
surrounded by mesenchyme. The adult pancreas is com-
posed of three major cell types—endocrine, exocrine, and
duct cells—all arranged in a stereotypic manner (Jensen,
2004; Murtaugh and Melton, 2003).
In recent years, many studies of pancreas development
have focused on understanding the specification of indi-
vidual cell types, especially endocrine cells (Wilson
et al., 2003). Comparatively less is known about the multi-
potent cells of the embryonic pancreas, although it is gen-
erally assumed that they are present in pancreatic buds.
Cells in the nascent pancreatic buds have a similar epithe-
lial morphology and stain broadly for Pdx1 and Ptf1a, two
transcription factors (TFs) required for pancreas develop-
ment (Jonsson et al., 1994; Kawaguchi et al., 2002; Offield
et al., 1996). Furthermore, lineage studies have shown
that cells expressing Pdx1 at this stage give rise to all
adult pancreatic cell types (Gu et al., 2002). However, it
is not known whether all of the Pdx1+ cells, or only a sub-
set of them, are multipotent. During the branching stage,
the pancreas becomes more complex in both structure
and cell-type composition, and there is currently no infor-
mation as to whether or where multipotent progenitors
exist at this stage. All molecular markers identified to
date, including Pdx1 and Ptf1a, are expressed in multiple
cell types during the branching stage, and none can be
used to distinguish multipotent cells from committed cell
types (Hale et al., 2005; Krapp et al., 1996; Sander et al.,
2000; Sussel et al., 1998). Indirect evidence, however,
suggests that multipotent progenitors are present in the
branching stage; for instance, it has been observed that
Ngn3+ endocrine progenitors are continuously produced
throughout embryogenesis from Ngn3 cells (Maestro
et al., 2003). Although these Ngn3 cells may simply rep-
resent an earlier endocrine progenitor, they could also
represent multipotent cells.
If multipotent pancreatic cells exist, where are they lo-
cated and how do they construct the branching structuresopmental Cell 13, 103–114, July 2007 ª2007 Elsevier Inc. 103
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potent cells reside within a specific domain, the ventricular
zone, with differentiated progeny migrating outward and
organizing into different structures (Jessell, 2000). Simi-
larly, in the gut, stem cells are localized at the base of
the villi, sending differentiated progeny toward the tips
(Fuchs et al., 2004). It is conceivable that a similar ‘‘multi-
potent domain’’ exists in the developing pancreas and that
it serves as an organizing center for pancreatic organo-
genesis.
To identify previously unappreciated compartments in
the pancreas, we performed genome-wide expression
analysis of the developing pancreas with >1,100 TFs. Sev-
eral discrete domains were recognized, representing the
mesenchyme, epithelium, and vasculature of the develop-
ing pancreas. The epithelium domain can be further
divided into two separate domains delineating the distal
tip and trunk of the branches. Molecular marker analysis
and genetic lineage tracing experiments suggest that cells
of the distal tip domain, which coexpress Pdx1, Ptf1a,
c-Myc, and Carboxypeptidase A1 (Cpa1), are multipotent
progenitors that are capable of generating all pancreatic
cell types, including exocrine, endocrine, and duct cells.
The outgrowth of tip progenitors leaves behind endocrine
and duct progeny that comprise the trunk of the branches.
The multipotent tip progenitors undergo a developmental
switch around midgestation (E14) and become exocrine
cells. Our findings reveal the existence of a distinct do-
main of multipotent progenitors in the developing pan-
creas and, combined with earlier studies, suggest amodel
of how pancreatic branching is coordinated with cell-type
specification.
RESULTS
Genome-Wide TF Expression Analysis Defines
Five Domains of Gene Expression within
the Developing Pancreas
A genome-scale, whole-mount in situ hybridization screen
was performed with a recently developed mouse TF
library that covers about 80% (1,100) of all predicted
mouse TFs (total, 1,400) (Gray et al., 2004). E9.5 em-
bryos and E14.5 dorsal pancreata were chosen for the
screen. E9.5 represents the earliest stage of pancreatic
organogenesis and E14.5 represents a stage at which
the developing pancreas is undergoing active growth,
branching, and cellular differentiation (Murtaugh and
Melton, 2003).
Of the 1,100 TF genes analyzed, we detected the
expression of 8 TF genes at E9.5 (see Figure S1 in the Sup-
plemental Data available with this article online) and 94 TF
genes at E14.5 (Table S1). The eight TF genes expressed
at E9.5 are also present in E14.5 pancreas (Figure S1 and
S2). Among TFs identified in the screen are many well-
studied pancreatic genes, including Pdx1, Ptf1a, Nkx2.2,
and Ngn3 (reviewed by Edlund, 2002 and Wilson et al.,
2003). In addition, we identified genes, the expression of
which, in the pancreas, has not been described previ-
ously, including Lisch7, Wbscr14, and Tbx3 (Table S1).104 Developmental Cell 13, 103–114, July 2007 ª2007 ElsevierThe whole-mount in situ samples provide a clear view of
overall expression patterns, but lack cellular resolution for
structures within the pancreas. In situ hybridizations on
tissue sections were performed with all 94 TFs identified
from the initial whole-mount screen (Figures 1F–1J). Of
the 94 genes, 60 yielded a clear, regionalized signal at
E14.5, and these could be classified into five general
patterns (Figures 1K–1O and Table S1). For simplicity,
we referred to them as ‘‘pan-epithelium,’’ ‘‘tip,’’ ‘‘trunk,’’
‘‘mesenchyme,’’ and ‘‘vascular.’’ Pan-epithelium genes,
such as Hex, are expressed specifically in pancreatic
epithelial but not mesenchymal cells (Figures 1A, 1F,
and 1K). Tip genes are confined to the distal tips of the
pancreatic epithelial tree (Figures 1B, 1G, and 1L, arrow-
heads), while trunk genes appear in cells scattered within
the trunk but not the tips of the branching epithelium
(Figures 1C, 1H, and 1M). In addition to these three epithe-
lial domains, the mesenchyme and vascular classes of
TFs havemesenchymal- and vascular-specific expression
patterns, respectively (Figures 1D, 1E, 1I, 1J, 1N, and 1O).
Different Pancreatic Precursors Are Localized
in Discrete Epithelial Domains
Given that all three major pancreatic cell types, including
exocrine, endocrine, and duct cells, derive from the epi-
thelium (Gu et al., 2002), we used specific markers to an-
alyze whether the tip and trunk epithelial domains contain
separate precursor populations.
Several tip genes, including Ptf1a, Mist1, and RBP-l
(Table S1), have been implicated in the development of
exocrine tissues (Beres et al., 2006; Lin et al., 2004; Pin
et al., 2001; Zecchin et al., 2004). We tested the exocrine
nature of the tip domain at E14.5 by double-labeled in situ
hybridization of selected tip genes withCarboxypeptidase
A1 (Cpa1) and Amylase, two markers of fully differentiated
exocrine cells. Complete overlap was observed (Fig-
ures 2A and 2B), suggesting that the tip domain is
occupied by exocrine precursors at E14.5. These data
are consistent with published results (Pictet and Rutter,
1972).
In contrast to tip genes, most trunk TFs identified are
well-established markers of endocrine precursors, with
the exception of vitamin D receptor (VDR) and Wbscr14,
the expression of which in the embryonic pancreas had
not been described before (Table S1). Double-labeled
in situ hybridization revealed that VDR and Wbscr14 par-
tially overlap with a number of endocrine genes (not
shown), suggesting that they are also expressed in endo-
crine cells. To visualize the extent of the pancreatic trunk
that is occupied by endocrine precursors, a mixture of
cRNA probes, including most of the endocrine precursor
markers (Ngn3, NeuroD, Pax4, Pax6, Isl1, Brn4, Myt1,
MafB, Arx,Wbscr14, and VDR) was used for in situ hybrid-
ization on E14.5 pancreas (Figure 2C). While the majority
of trunk cells were labeled (Figure 2C), some appear to
have been negative (Figure 2C, arrows). It is noteworthy
that the expression of endocrine genes did not extend in-
side the tips (Figure 2C, arrowheads). These data indicate
that endocrine precursor cells reside exclusively within theInc.
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Multipotent Progenitor Domain of the PancreasFigure 1. Genome-Wide TF Expression Analysis of the Developing Pancreas
(A–E)Whole-mount in situ hybridization screen was performedwith1,100mouse TFs on E14.5 dorsal pancreas. A total of 94 genes showed specific
expression that can be classified into five broad patterns, as represented by the expression of Hex, Nr5a2, Pax6, Osr2, and Sox18, respectively.
(F–J) Corresponding section in situ hybridization images of the five patterns. Arrowheads in (G) and (H) indicate tips of the branching pancreatic tree.
Pancreatic epithelia are outlined.
(K–O) Schematic drawings of pancreatic gene expression patterns.trunk of the pancreatic branches. Due to lack of definitive
precursor markers for the pancreatic duct lineage, we
could not assess where duct precursors are localized
within the branching structure.
To further confirm that the tip and the trunk of the
pancreatic branches at E14.5 represent discrete domains,
we performed double-labeled in situ hybridization ofCpa1
(tip) and the endocrine progenitor marker Ngn3 (trunk)
(Gradwohl et al., 2000; Gu et al., 2002). No overlap was
observed (Figure 2D). Together, our analysis suggests
that the tip and trunk of the branching pancreatic tree at
E14.5 are separate domains and contain different precur-
sor populations.
We further analyzed the expression of tip genes at
E12.5, when pancreatic branching morphogenesis has
just begun. Although most tip genes yielded no staining
at this early stage, signals were detected for C-myc,
Ptf1a, and Cpa1 in the newly formed branches (Figures
2E–2G, arrowheads). Interestingly, when one tip divides
into two or more tips, the tip markers, Cpa1, Ptf1a, and
c-Myc, are downregulated in the cleft region before overt
morphological changes occur (Figure 2G, hollow arrow-
heads, and Figures S5A and S5B). Double-labeled in situ
hybridization of Ptf1a, c-Myc, and Cpa1 shows that they
are coexpressed in the same population of tip cells atDeveE12.5 (Figures S5A and S5B). In addition, Ngn3+ endo-
crine cells and Cpa1+ tip cells occupy distinct domains
(Figure 2H). Unlike at E14.5, however, the tip cells at
E12.5 do not express the exocrine markers Amylase and
Elastase (data not shown). These data raised the question
of whether the Ptf1a+cMyc+Cpa1+ tip cells that exist
before E14.5 are multipotent progenitors or committed
exocrine precursors.
Distal Tip Cells Represent a Novel, Fast-Proliferating
Cell Type
Among the three early tip genes, c-Myc expression,
though concentrated in the tips, is also detected at lower
levels in other epithelial cells (data not shown). Ptf1a
expression is rather weak before E12.5, and cannot be
easily or reliably detected by antibody staining or in situ
hybridization. In contrast, Cpa1 expression is specific to
the tip cells and readily detectable by antibody staining
and in situ hybridization. We therefore used Cpa1 as
a marker to further characterize the tip cells during early
pancreatic branching morphogenesis.
Cpa1mRNA is first detected in E9.5 and protein expres-
sion starts around E10.5 in the pancreatic buds (data not
shown). At E11.5, Cpa1 is expressed in a scattered popu-
lation of epithelial cells (Figures 3A, 3E, and 3I). Shortlylopmental Cell 13, 103–114, July 2007 ª2007 Elsevier Inc. 105
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Multipotent Progenitor Domain of the PancreasFigure 2. The Tip and Trunk of Epithelial Branches Contain Different Precursor Cells
(A and B) At E14.5, tip markers c-Myc and Ptf1a overlap completely with exocrine markers Carboxypeptidase A1 (Cpa1) (A) and Amylase (B) (arrow-
heads), suggesting that the branching tips are occupied by exocrine cells at this stage.
(C) The trunk of the pancreatic branches is largely occupied by endocrine cells at E14.5, as revealed by in situ hybridizationwith a cocktail of endocrine
precursor (E.P.) probes, including Ngn3, Pax4, Pax6,NeuroD, Isl1, Brn4,Myt1,MafB, Arx,Wbscr14, and VDR. No staining was observed within distal
tips (arrowheads). Some trunk cells appear to express none of the E.P. markers (arrows). Asterisks indicate the early islets.
(D) No overlap was observed between the tip marker Cpa1 (arrowheads) and the trunk maker Ngn3 at E14.5 by double-labeled in situ hybridization.
(E–H) Section in situ hybridization of dorsal pancreata at E12.5, when pancreatic branching morphogenesis had just begun. Strong Cpa1 expression
was detected in the newly formed branches (G), whereas the expression of two other tipmarkers, c-Myc andPtf1a, is quiteweak at this stage (E and F).
Cpa1 and Ngn3 again exhibit nonoverlapping expression patterns (H). Arrowheads indicate branching tips. Hollow arrowheads indicate the ‘‘cleft’’
region between future branches where Cpa1 is downregulated.after E11.5, branching of the pancreas begins. By E12.5,
there are well-formed primary branches, and Cpa1 ex-
pression is now largely restricted to the branching tips
(Figures 3B, 3F, and 3J, arrows). The tip-restricted expres-
sion pattern of Cpa1 persists through successive branch-
ing and growth of the pancreatic tree (Figures 3C, 3D, 3G,
3H, 3K, and 3L). Note that Cpa1 protein levels vary among
tip cells, perhaps reflecting their different mitotic stages.
At all embryonic stages examined, Cpa1+ cells do not
express mature endocrine hormones (Figures 3A–3D) or
the early endocrine progenitor marker, Ngn3 (Figures
3E–3H). In contrast, all Cpa1+ cells do express Pdx1 and
constitute a subset of Pdx1+ epithelial cells (Figures 3I–
3L). Quantification demonstrates that Cpa1+ tip cells rep-
resent 13.3%, 13.6%, and 16.8% of total Pdx1+ cells at
E12.5, E13.5, and E14.5, respectively. In addition, Cpa1+
tip cells proliferate 3–5 times faster than trunk epithelial
cells, as revealed by staining with the mitotic marker
phospho-histone H3 (Figures 3M, 3M0, and 3N). Thus,
the Ptf1a+cMycHighCpa1+ tip cells represent a novel, fast-
proliferating subset of the general pancreatic precursors
marked by Pdx1 expression.
Genetic Lineage Tracing of the Tip Progenitors
To determine whether the tip cells constitute multipotent
progenitors or committed cells, we generated a106 Developmental Cell 13, 103–114, July 2007 ª2007 Elsevier ICpa1CreERT2mouse line that expresses an inducible form
of Cre recombinase (CreERT2) from the Cpa1 genomic
locus (Figures S3) (Metzger and Chambon, 2001). By
crossing this mouse line with the reporter line, R26R, ad-
ministration of tamoxifen (TM) allows permanent marking
of Cpa1-expressing cells at designated developmental
stages and allows us to follow the fate of Cpa1 progeny
through subsequent development (Figure 4A).
To validate the Cpa1CreERT2 line, we first examined
whether CreERT2 expression is restricted to Cpa1+ cells
and whether CreERT2 activation is strictly dependent
upon TM. Cpa1CreERT2;R26R animals were labeled with
one TM injection at E13.5 (Figure 4C) and analyzed 20 hr
later. Uninjected animals served as controls (Figure 4B).
Many bgal+ cells were present in the pancreas of TM-
injected embryos (Figure 4C), which all coexpress Cpa1
(Figure 4C, arrowheads). In contrast, no bgal+ cells were
detectable in the absence of TM (Figure 4B). These data
show that CreERT2 expression is restricted to Cpa1+ cells
and, importantly, activation of CreERT2 is strictly TM de-
pendent. A similar experiment on adult animals confirmed
that CreERT2 expression is restricted to adult exocrine
acini (Figure 4E, arrowhead), but not islets (Figure 4E,
arrow) or ducts. Again, CreERT2 activation is TM depen-
dent (Figure 4D). A maximum of 20% labeling efficiency
is observed in the adult (4 mg TM 3 3).nc.
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Multipotent Progenitor Domain of the PancreasFigure 3. Cpa1 Labels a Distinct Tip Progenitor Population
Confocal immunofluorescent images of pancreatic tissues. Cpa1 expression is evident in a scattered population of cells in E11.5 pancreatic bud (A, E,
and I) and restricts to the branching tips of the growing pancreatic tree starting around E12.5 (B–D, F–H, and J–L; arrows). There is no overlap between
Cpa1 and endocrine hormones (A–D), or between Cpa1 and the endocrine progenitor marker, Ngn3 (E–H), at all stages examined. In contrast, all
Cpa1+cells co-express Pdx1 (I–L, arrows). Ecad: E-cadherin, amarker of pancreatic epithelial cells. Endo: the four major endocrine hormones (insulin,
glucagon, somatostatin, and pancreatic polypeptide) were simultaneously recognized with a mixture of antibodies. Hollow arrowheads indicate early
glucagon+ endocrine clusters. (M) Mitotic cells in E12.5 pancreas was recognized by the G2/M phase marker phospho-Histone H3 (PH3). Arrows
indicate mitotic cells. (M0) Corresponding DAPI staining of nuclei. (N) Quantitative analysis of the proliferation rate of Cpa1+ versus Cpa1 pancreatic
epithelial cells. Percentile was calculated as Cpa1+ mitotic epithelial cells (tip, red bar) and Cpa1mitotic epithelial cells (trunk, blue bar) against the
total number of epithelial cells.TM has been shown to induce nuclear translocation of
CreERT2 within 6 hr and to remain in the nucleus for ap-
proximately 36 hr (Ahn and Joyner, 2004; Danielian
et al., 1998). Consistent with these reports, TM injection
at E8.0, 36 hr before the onset of Cpa1 expression,
yielded no bgal+ cells in Cpa1CreERT2;R26R embryos,
whereas many bgal+ cells were present if TM was given
at E9.5 (data not shown), suggesting that CreERT2 is active
from 12 to 36 hr after injection.DeveloNote that, in addition to CreERT2, an IRES-H2BYFP ele-
ment was knocked into the Cpa1 locus (Figure S2). The
presence of the IRES element should allow coexpression
of H2BYFP with CreERT2 from the Cpa1 locus. However,
we only detect YFP autofluorescence in the adult, but not
the embryonic pancreas of Cpa1CreERT2 animals. This is
likely due to the fact that the expression level behind the
IRES element is generally much reduced, and that Cpa1
expression in the embryos isweaker than that in the adults.pmental Cell 13, 103–114, July 2007 ª2007 Elsevier Inc. 107
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Multipotent Progenitor Domain of the PancreasFigure 4. Strategy of Genetic Lineage Tracing with Cpa1CreERT2 Knockin Mouse Line
(A) An inducible form of Cre recombinase (CreERT2) expressed specifically from the Cpa1 locus will remove the floxed stop cassette from the R26R
allele only in the presence of TM, which allows permanent bgalactosidase (bgal) expression in the labeled cells as well as all their progeny. Triangles
represent loxP sites.
(B and C) Immunofluorescence of E14.5 Cpa1CreERT2;R26R pancreata. No bgal+ cells were detected in the absence of TM (B) whereas many Cpa1+
bgal+ cells were observed in the presence of TM (C, arrowhead).
(D and E) LacZ staining of two-month old adult Cpa1CreERT2;R26R animals. With TM injection, LacZ signal was detected in the exocrine compart-
ment of the pancreas (E, arrowhead), but not islets (E, arrow) or ducts. In the absence of TM, no lacZ signal was detectable (D). Samples in (D) and (E)
were counter-stained with Hematoxylin and Eosin.Cpa1+ Tip Progenitors are Multipotent and Give Rise
to Endocrine, Exocrine, and Duct Cells before E14
Cpa1CreERT2;R26R embryos were labeled with a single
pulse of TM at different developmental stages and ana-
lyzed at E18.5 (Figure 5 and Figures S3A). Cpa1+ cells
marked at E9.5, E10.5, E11.5, and E12.5 gave rise to all
three major cell types of the pancreas (Figures 5A–5C,
5E–5G, 5I–5K, and data not shown)—i.e., endocrine cells
(Figures 5A–5C, arrows), exocrine cells (Figures 5E–5G,
hollow arrowheads), and duct cells (Figures 5E–5G, white
arrowheads). Notably, TM injections at both E11.5 and
E12.5 should label Cpa1+ cells when they reside within
the branching tips (labeling occurs around E12–E13 and
E13–E14, respectively), suggesting that the early branch-
ing tip cells are multipotent progenitors. In sharp contrast,
Cpa1+ cells marked at E13.5 or after generate only exo-
crine progeny (Figures 5D, 5H, and 5L, arrowheads).
The observation that Cpa1+ tip cells produce multiple
pancreatic cell types before E14 does not necessarily
mean that Cpa1+ cells are a homogeneous population of
multipotent progenitor cells. It is possible that they are
composed of a mixture of separate progenitors. To distin-
guish between these two possibilities, we examined
clones of cells that likely derive from single Cpa1+ cells
(Figures S4). By varying TM doses, we first determined
that, at 0.5 mg/animal, only a small number of discrete
clusters of cells (010 clusters) are present (Figures S4D
and S4E, arrows), likely representing clones. In contrast,
at 2 mg/animal, around 5%–20% of the pancreatic cells
are labeled (Figures S4F). No lacZ-positive cells were
ever observed in the absence of TM (Figures S4A). Clones
of cells labeled at E11.5 and harvested at E13.5 typically
contain just a few cells (Figures S4B and S4C), whereas
clones harvested at E18.5 generally contain dozens of
cells (Figures S4G and S4H).108 Developmental Cell 13, 103–114, July 2007 ª2007 ElsevieFor clonal analysis, pancreata with a single lacZ+ clone
or two well-separated clones were selected. Individual
clones were sectioned through their entirety and stained
with insulin to visualize the primitive islets. The three major
pancreatic cell types can be easily distinguished based on
insulin and lacZ signals: endocrine cells reside within the
primitive islets (Figures S4I, arrows); duct cells exhibit an
elongated shape and reside within ducts (Figures S4I,
black arrowheads); and exocrine cells appear as large
round cells that are part of a rosette structure (Figures
S4I, white arrowheads). Out of 43 clones examined, 32
(74%) are composed of exocrine, endocrine, and duct
cells (Figures S4). In addition, a small number of clones
were found to contain either a mixture of two cell types
or only exocrine cells (Figures S4). Although the number
of clones examined is rather small, these results strongly
suggest that individual Cpa1+ tip progenitors labeled
between E12 and E13 are tripotent.
Multipotent Tip Progenitors Give Rise to Mature
Endocrine Cells in a Stepwise Fashion
We next sought to visualize the various differentiation
steps that lead from the Cpa1+ multipotent tip progenitors
tomature pancreatic cells. Among the threemajor pancre-
atic cell types, the differentiation steps of the endocrine
cells are best understood (Wilson et al., 2003). The earliest
recognizable endocrine progenitors are Ngn3+ (Gradwohl
et al., 2000; Schwitzgebel et al., 2000), which subse-
quently give rise to a number of late progenitor cell types
expressing markers such as NeuroD, Pax4, Pax6, Arx,
etc. (Wilson et al., 2003). Mature endocrine cells derive
from these late progenitor cells.
To visualize each step of this differentiation process, we
labeledCpa1CreERT2;R26R embryoswith a single dose of
TM at E12 (labeling E12.5–E13.5) and harvested them onr Inc.
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Cpa1CreERT2;R26R embryoswere labeledwith one dose of TM at different embryonic stages. Pancreatawere harvested at E18.5. Cpa1+ cells pulsed
at E10.5, E11.5, and E12.5 (labeling occurs at E11–12, E12–13, and E13–14, respectively) gave rise to endocrine (A–C, arrows), exocrine (E–G, hollow
arrowheads), and duct (E–G, white arrowheads) progeny. In contrast, Cpa1+ cells pulsed at E13.5 (labeling E14–15) generate only exocrine (H, hollow
arrowheads), but not endocrine (D) or duct (H) cells. Endo, four major endocrine hormones (insulin, glucagon, somatostatin, and pancreatic polypep-
tide) were simultaneously recognized with a mixture of antibodies; Amy, Amylase, a mature exocrine marker; DBA, a pancreatic duct marker. (I–L)
Summary of the lineage of Cpa1+ cells at different embryonic stages. En, endocrine; Ex, exocrine; D, duct.three successive days for analysis (Figure 6 and Figures
S3B). One day after TM injection, the initial population of
TM-responsive cells expresses both bgal and Cpa1 as ex-
pected (Figure 6A, arrows). Consistent with the labeling of
an early multipotent progenitor cell type, these cells were
negative for the early endocrine marker, Ngn3 (Figure 6D),
the late endocrine marker, Pax6 (Figure 6G), and all endo-
crine hormones (Figure 6J). Starting from 2 days after la-
beling, we observed that Cpa1 bgal+ cells appear in the
trunk region of the branches (Figures 6B and 6C, arrow-
heads) in addition to Cpa1+bgal+ cells residing in the tips
(Figures 6B and 6C, arrows). This observation, together
with the data that most Cpa1+ cells are multipotent before
E14 (Figure 5 and Figures S4), suggests that some Cpa1+
are capable of limited self-renewal (i.e., producing more
Cpa1+ multipotent tip cells as well as Cpa1 differentiated
progenies).
Starting from E14, some progeny of Cpa1+ cells labeled
at E12 begin to express Ngn3 (Figures 6E and 6F, arrow-
heads), indicating that they have become committed
endocrine progenitors. One day later, at E15, Pax6+bgal+Develate endocrine progenitors, as well as endo+bgal+ mature
endocrine progenies, were detected (Figures 6I and 6L).
These data suggest that Cpa1+ cells appear to self-renew
(making more Cpa1+ cells) and lay down daughters that
go through a series of differentiation steps to generate
mature pancreatic cells in vivo (Figure 6M).
DISCUSSION
Formation of the mammalian pancreas as a complex
three-dimensional organ requires timely generation, mi-
gration, and differentiation of different cell types from
multipotent progenitors. We performed genome-wide TF
expression analysis of the developing pancreas and dis-
covered multiple distinct gene expression domains that
indicate the presence of specific pancreatic progenitor
domains. Using a combination of serial immunofluores-
cence and genetic lineage tracing experiments, we pro-
pose that one type of multipotent pancreatic progenitor
can be recognized by a combination of markers
(Pdx1+Ptf1a+cMycHighCpa1+), resides specifically at thelopmental Cell 13, 103–114, July 2007 ª2007 Elsevier Inc. 109
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Cpa1+Multipotent Progenitors toMature
Endocrine Cells
Cpa1CreERT2;R26R embryos were labeled
with one dose of TM at E12 and harvested
1–3 days after injection to follow the fate of
the labeled cells.
(A–C) One day after pulse labeling, all bgal+
cells coexpress Cpa1 (A, arrow). Starting
from 2 days after labeling (B and C), while
some bgal+ cells maintain Cpa1 expression
and reside in the branching tips (B and C,
arrows), others lose Cpa1 expression and ap-
pear in the trunk region (B and C, arrowheads).
(D–L) Cpa1+ cells labeled at E12 gave rise to
Ngn3+ early endocrine progenitors starting
from 2 days after TM (E and F, hollow arrow-
heads), and Pax6+ late progenitors at 3 days
post TM (I, hollow arrowheads). Hormone-
producing mature endocrine cells also appear
3 days after TM (L, hollow arrowheads). Endo,
all four major endocrine hormones (insulin, glu-
cagons, somatostatin and PP) were detected
with a mixture of antibodies.
(M) Summary of the E12 pulse-chase experi-
ment.branching tips of the growing pancreatic tree, and that its
proliferation and differentiation play major roles in the
branching morphogenesis of the pancreas. In addition,
our analysis of TFs has uncovered pancreatic genes that
are likely to play important roles in pancreas development
and disease.
Domain Organization of the Developing Pancreas
Our data show that regionalized gene expression patterns
are created very early and aremaintained through succes-
sive branching and growth of the pancreatic tree. The em-
bryonic pancreas contains relatively few gene expression
domains, in contrast to the developing nervous system
and kidney, where many more expression patterns have
been discovered in similar screen efforts (Gray et al.,
2004; A.P. McMahon, personal communication). Given110 Developmental Cell 13, 103–114, July 2007 ª2007 Elsevierthe large number of cell types that exist in the adult brain
and kidney, the simple domain organization of the devel-
oping pancreas may reflect the relatively small number of
cell types that are produced in the developing pancreas.
What causes the tip and trunk of the pancreatic branches
to have different gene expression patterns? In other devel-
oping organ systems, such as the lung, nervous system,
and limb bud, focal sources of morphogens are responsi-
ble for creating different domains of gene expression in
an otherwise homogeneous tissue (Hogan, 1999; Jessell,
2000). Such focal sources of morphogens have not been
identified in the developing pancreas. In fact, although
many signalingmolecules are expressed in the developing
pancreas, few exhibit regionalized expression. One nota-
ble exception is the Notch pathway. Notch receptors
and Hes1, an effector of Notch pathway, have elevatedInc.
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Multipotent Progenitor Domain of the PancreasFigure 7. Multipotent Progenitors Guide Pancreatic Organogenesis
(A) Cpa1+ multipotent progenitors give rise to exocrine, endocrine, and duct cells in vivo and may undergo limited self-renewal.
(B) Early pancreatic buds are composed primarily of multipotent progenitors. At the onset of branching morphogenesis (E12), the multipotent cells
may divide asymmetrically such that they are propelled away from the center of the pancreatic buds, thus producing branches. Continued fast pro-
liferation and differentiation of these progenitors into endocrine and duct cells generate the trunk of the branches. When the branching tip divides,
Cpa1 downregulates in the cleft region. Around E14, Cpa1+ tip cells restrict to exocrine fate during the secondary transition.expression in distal tips of the embryonic pancreatic endo-
derm (Apelqvist et al., 1999;Wang et al., 2005). Similarly to
other developing organ systems, the Notch pathway func-
tions in pancreas to suppress differentiation and maintain
progenitors in an undifferentiated state (Apelqvist et al.,
1999; Esni et al., 2004; Hald et al., 2003; Jensen et al.,
2000; Murtaugh et al., 2003). These studies suggest that
tip cells of the branching pancreas are actively maintained
in a progenitor state by elevated Notch signaling. It is un-
clear, however, as to what causes the preferential activa-
tion of Notch pathway in the early distal tips. Although
Fgf10 signaling has been reported to promote or maintain
Notch expression in embryonic pancreas (Hart et al., 2003;
Norgaard et al., 2003), pancreatic expression of Fgf10 is
diffuse and rather transient (Bhushan et al., 2001).
In other tissue and organ systems, it has been shown
that stem cells reside in specific ‘‘niches,’’ or microenvi-
ronments (Fuchs et al., 2004). Similarly, the multipotent
tip progenitors of the embryonic pancreas may also have
a supporting niche, suggesting that mesenchymal cells
surrounding the branching tips may exhibit different prop-
erties. However, no differential gene expression has been
observed in the developing pancreatic mesenchyme.
Multipotent Progenitors of the Pancreas
Our genetic lineage tracing studies show that one type
of multipotent pancreatic cell is localized specifically to
the branching tips. Beside the tip cells, most of the trunk
cells appear to be committed endocrine progenitors
(Figure 2C). In addition, there is a population of trunk epi-
thelial cells that do not express any of the known endo-
crine progenitor markers (Figure 2C). Since the trunk of
the developing pancreatic tree is the predecessor of the
adult duct system, we favor the idea that these unidenti-
fied cells represent duct progenitors. Nevertheless, we
cannot rule out the possibility that some of these Cpa1
cells are also multipotent. Further genetic studies with
additional molecular markers should help resolve this
important issue.DevelOur lineage analysis is a test of developmental fate, but
not potential of the Cpa1+ cells. It remains possible that
the Cpa1+ cells are competent to produce endocrine/
duct cells beyond E14, but the inducing cues are absent.
However, recent observations from our laboratory sug-
gest that transplanting dissociated E16.5 or E17.5 pan-
creatic cells into cultured E10.5 pancreatic buds fail to
produce clones with multilineage contribution. In contrast,
similar experiments with cells collected before E14 re-
sulted in multilineage clones (R.I. Sherwood and D.A.M.,
unpublished data). These observations support our con-
clusion that multipotent pancreatic cells disappear after
E14.0, although it is formally possible that a small number
may persist into later development.
Genetic studies have shown that, during adulthood,
beta cells do not come from multipotent progenitors
(Dor et al., 2004; Brennand et al., 2007; Teta et al.,
2007). Furthermore, pancreatic organ size appears to be
constrained by the initial progenitor population, and there
is little cellular compensation (Stanger et al., 2007). These
findings, together with the results of our analysis, suggest
that Cpa1+ cells before E14 may represent the only multi-
potent pancreatic progenitors.
Integrating Pancreatic Branching
and Cell Type Specification
Our data suggest a simple model of how pancreatic
branching is integrated with cell type specification. The
early pancreatic bud consists primarily of multipotent
progenitors (Figure 7A). When branching begins,
Pdx1+Ptf1a+cMycHighCpa1+ multipotent cells divide rap-
idly, and possibly in a directional fashion, such that they
are propelled outward from the epithelial plane, thus initiat-
ing branches. The proliferation and outgrowth of themulti-
potent tip cells leave behind their more differentiated
progeny (i.e., the endocrine and duct cells), which make
up the trunk of the branches (Figure 7B). Eventually, endo-
crine cells differentiate and migrate out of the epithelium,
leaving the trunk to be made entirely of duct cells. Atopmental Cell 13, 103–114, July 2007 ª2007 Elsevier Inc. 111
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Multipotent Progenitor Domain of the Pancreasmidgestation during the so-called ‘‘secondary transition’’
(Pictet and Rutter, 1972), tip progenitors undergo a devel-
opmental switch that converts them into exocrine cells
(Figure 7B).
Pancreatic branching continues after the secondary
transition. The mechanism for continued branching, how-
ever, remains unknown. In addition, we have observed
that the timing of conversion from multipotent to acinar
fate is not synchronized, with Amylase expression appear-
ing in scattered tip cells from E13.5. Reduced production
of endocrine and duct cells at these later stages may ex-
plain why an earlier study has suggested that duct cells
are only specified before E12.5 (Gu et al., 2002). Themeth-
odology we used to detect duct cells (whole-mount X-gal
staining of E18.5 pancreas) may be more sensitive than
that employed in the previous study (section staining of
alkaline phosphatase [AP] on 2 month adult pancreas).
Many mammalian organs, including the lung, kidney,
mammary gland, and prostate gland, develop via branch-
ing morphogenesis (Davies, 2002; Hogan and Kolodziej,
2002). The branching tips of many of these organs express
regionalized markers and exhibit increased proliferation
(Fisher et al., 2001; Mollard and Dziadek, 1998; Xue
et al., 2001). A recent study of developing kidney provided
evidence that tip cells of the ureteric bud are bipotential
and contribute to both tips and trunks (Shakya et al.,
2005). Together with our analysis, these studies suggest
that it may be a common theme for all branching organs
to locate their stem/multipotent cells at tips.
Cpa1 as a Multipotent Progenitor Marker
The current consensus view is that Pdx1 marks multi-
potent pancreatic progenitor cells. Although this is likely
to be the case at the pancreatic bud stage, Pdx1 con-
tinues to be expressed broadly throughout early embryo-
genesis, and cannot be used to distinguish between
different progenitor pools. Cpa1, on the contrary, marks
only a subset of Pdx1+ cells and these cells are multi-
potent in vivo before E14. Although our data show that
these multipotent tip cells are positive for Pdx1, Ptf1a,
c-Myc, and Cpa1 and negative for differentiated lineage
markers, we propose that a simpler combination of
markers (Pdx1+Cpa1+Amylase) is sufficient to unambig-
uously identify multipotent pancreatic progenitor cells
in vivo and perhaps in vitro as well.
It is noteworthy that the expression pattern of Cpa1 is
highly reminiscent of that of the pancreatic TFPtf1a (Krapp
et al., 1996). Expression of Ptf1 first appears around E10
and later restricts to exocrine tissues (Krapp et al.,
1996). Due to weak expression of Ptf1a before E12.5, we
were not able to assess whether Cpa1 and Ptf1a are
always coexpressed in individual cells before E12.5. Nev-
ertheless, it is likely that Ptf1a controls Cpa1 expression.
The mutant phenotype of Ptf1a suggests that it plays a
critical role in specifying the early pancreatic multipotent
progenitors (Kawaguchi et al., 2002). This is consistent
with the idea that Cpa1 marks multipotent cells.
The ability to identify multipotent pancreatic progeni-
tors has practical implications. Islet transplantation has112 Developmental Cell 13, 103–114, July 2007 ª2007 Elsevierecently been shown to be an effective method to treat
type I diabetes patients (Lakey et al., 2006). To generate
large amounts of beta cells for transplants, many ongoing
efforts are focused on the directed differentiation of beta
cells from embryonic stem cells. As an important interme-
diate cell type in these cultures, it is critical to recognize
the early multipotent pancreatic precursors so that their
survival and in vitro expansion can be optimized. Addition-
ally, it would also be interesting to see whether such
Pdx1+Cpa1+Amylase cells reappear in the adult pan-




Whole-mount in situ hybridization screen with the TF library on E9.5
mouse embryos and E14.5 pancreata was performed essentially as
described previously (Gray et al., 2004). Briefly, a plasmid library that
represents 1,100 independent mouse TFs served as template for
PCR amplification of the inserts. Digoxigenin-labeled cRNA probes
were made directly from the PCR products using T7, T3, or Sp6 poly-
merases (Roche) and purified through Micro Bio-spin columns (Bio-
Rad). E9.5 embryos and E14.5 pancreata were dissected and fixed
with 4% paraformaldehyde overnight. After proteinase K treatment,
the pancreata were hybridized with individual cRNA probes. Posthy-
bridization washes and antibody incubation were performed with a
BioLane in situ hybridization machine (Holle and Huttner, AG). Signals
were developed with BM purple (Roche). Samples were cleared in
80% glycerol and photographed.
Single- and double-labeled section in situ hybridization on paraffin-
embedded tissues was performed as previously described (Gray et al.,
2004). For double-labeled in situ hybridization, two different probes
were labeled with either digoxigenin or fluorescein. The first probe
was detected with AP-conjugated anti-digoxigenin antibody, and
developed with NBT/BCIP (Biorad), which yields a purple precipitate.
After the NBT/BCIP reaction, the AP-conjugated anti-digoxigenin anti-
body was inactivated at 85C and the slides were subsequently incu-
bated with AP-conjugated anti-fluorescin antibody and detected with
INT/BCIP (Roche), which yields a reddish brown precipitate.
Immunohistochemistry
Mouse embryos and pancreata were fixed by immersion in 4% para-
formaldehyde from 1 to 6 hr depending on the age. Samples were
subsequently incubated in 30% sucrose solution overnight and
embedded with OCT compound (Vector). The following primary anti-
bodies were used: rat anti-E-cadherin (Zymed), rabbit anti-carboxy-
peptidase A1 (Biogenesis), goat anti-Ngn3 (Santa Cruz), Guinea pig
anti-insulin (Dako), guinea pig anti-glucagon (Linco), guinea pig anti-
pancreatic polypeptide (Linco), goat anti-somatostatin (Santa Cruz),
goat anti-Pdx1 (Santa Cruz), guinea pig anti-Pdx1 (gift of Dr. Chris
Wright), rabbit anti-bgalactosidase (Cappel), goat anti-bgalactosidase
(Biogenesis), rabbit anti-Amylase (Sigma), sheep anti-Amylase (Ab-
cam), mouse anti-Ki67 (BD PharMingen), rabbit anti-Pax6 (Chemicon),
and FITC-conjugated mouse anti-phospho-histone H3 (Upstate).
Rodamin-red-X, FITC, Cy5, and Alexa dye-conjugated donkey sec-
ondary antibodies were obtained from Jackson Immunoresearch Lab-
oratories and Molecular Probes Inc. Biotin-labeled Dolichos biflorus
agglutinin is from Vector Laboratories Inc.
Generation of Cpa1CreERT2 Knockin Mice
The knockin vector for Carboxypeptidase A1 (Cpa1) was generated by
inserting a CreERT2-IRES-H2BYFP-ACN cassette between a 2.7 kb 50
arm and a 4.5 kb 30 arm. Both arms were derived from PCR amplifica-
tion of AV3 ES cell genomic DNA and confirmed by sequencing. ACN
is a neomycin selection cassette that self-deletes during germ liner Inc.
Developmental Cell
Multipotent Progenitor Domain of the Pancreastransmission (Bunting et al., 1999). The linearized construct was elec-
troporated into AV3 ES cells. After neomycin selection, positive clones
were picked and screened by Southern blot with both a 50 probe and
a 30 probe. Three recombined ES clones were injected into C57BL/6
blastocysts. Two gave germ line transmission. PCR analysis confirmed
that the ACN selection cassette was self-deleted from all germ line-
transmitted animals. Since Cpa1CreERT2/ homozygous animals
are healthy and fertile, this mouse line was maintained as homozy-
gotes. The Rosa-loxP-stop-loxP-lacZ reporter mice (R26R) were pur-
chased from the Jackson Laboratory andmaintained as homozygotes.
All animal experiments described in this article have been approved




females to produce double-heterozygous Cpa1CreERT2;R26R em-
bryos. The noon of the day of a vaginal plug was designated as E0.5.
We have found that TMdoses over 2mg per pregnant female (weighing
30–40 g each) induced significant embryonic lethality. All embryonic
experiments were performed with less than 2 mg TM per animal given
intraperitoneally.
Supplemental Data
Supplemental Data, including five additional figures and one table, are
available online at http://www.developmentalcell.com/cgi/content/
full/13/1/103/DC1/.
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